Chronic Graft Versus Host Disease Active Not Recruiting Phase 2 Trials for DB00188 (Bortezomib)

Also known as: Chronic Graft-Versus-Host-Disease / Chronic Graft-Versus-Host Disease / Chronic Graft vs Host Disease / Chronic graft versus host disease / CGVHD / Chronic Graft-vs.-Host Disease / Chronic Graft-Versus Host Disease / Chronic Graft vs. Host Disease / Chronic GVHD / Chronic GVH disease

DBCOND0039599 (Chronic Graft Versus Host Disease)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT01158105Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)Treatment